EMN
Eastman Chemical Company
Stock
$64.87+0.82 (+1.28%)Close Oct 2, 2026
Income statement
| Line | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $9.5B | $9.0B | $9.6B | $9.5B | $9.4B | $8.1B | $7.2B | $5.8B |
| Cost of revenue | $7.2B | $6.7B | $7.1B | $7.3B | $6.6B | $6.3B | $5.6B | $4.4B |
| Gross profit | $2.4B | $2.4B | $2.6B | $2.2B | $2.8B | $1.8B | $1.6B | $1.5B |
| R&D | $227M | $223M | $242M | $227M | $193M | $198M | $159M | $152M |
| SG&A | $729M | $707M | $771M | $755M | $645M | $644M | $481M | $434M |
| Other operating expenses | — | $44M | $183M | $77M | $76M | $120M | — | $29M |
| Operating income | $1.5B | $1.4B | $1.4B | $1.2B | $1.9B | $800M | $937M | $844M |
| Non-operating income | −$243M | −$334M | −$255M | −$172M | −$183M | −$151M | −$56M | −$224M |
| Pretax income | $1.3B | $1.0B | $1.1B | $990M | $1.7B | $649M | $881M | $620M |
| Taxes | −$95M | $195M | $281M | $239M | $514M | $212M | $235M | $195M |
| Net income | $1.4B | $854M | $848M | $751M | $1.2B | $437M | $646M | $425M |
| Diluted EPS | $9.47 | $5.75 | $5.66 | $4.97 | $7.44 | $2.93 | $4.52 | $2.88 |
| Diluted shares | 146.1M | 148.4M | 149.8M | 151.1M | 156.5M | 149.1M | 143.1M | 147.8M |
| Revenue growth | +6.0% | −6.6% | +1.3% | +1.9% | +15.4% | +12.9% | +22.9% | — |
| Gross margin | 24.7% | 26.2% | 26.7% | 23.3% | 29.7% | 21.7% | 21.9% | 25.0% |
| Operating margin | 16.0% | 15.4% | 14.3% | 12.2% | 19.9% | 9.9% | 13.1% | 14.4% |
| Net margin | 14.5% | 9.5% | 8.8% | 7.9% | 12.5% | 5.4% | 9.0% | 7.3% |